Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is -17.42% vs 77.71% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -87.54% vs 304.92% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is -53.58% vs 1,821.02% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 13.78% vs -38.36% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
Compare Quarterly Results Of Orchid Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is -17.42% vs 77.71% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 15.57% vs 7.68% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -87.54% vs 304.92% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 156.59% vs -119.39% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -53.58% vs 1,821.02% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 348.23% vs -117.36% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 13.78% vs -38.36% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -2.19% vs -34.86% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






